ahc 52 has been researched along with dihydropyridines in 7 studies
| Studies (ahc 52) | Trials (ahc 52) | Recent Studies (post-2010) (ahc 52) | Studies (dihydropyridines) | Trials (dihydropyridines) | Recent Studies (post-2010) (dihydropyridines) |
|---|---|---|---|---|---|
| 7 | 0 | 0 | 5,022 | 529 | 969 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 6 (85.71) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ebisu, H; Inaba, M; Mitsuhashi, J; Shinoda, H; Tsuruo, T | 1 |
| Inaba, M; Shinoda, H; Tsuruo, T | 1 |
| Kobayashi, Y; Nagatake, H; Shigenobu, K; Tanaka, H; Tsuruo, T; Watanabe, N; Yamamoto, T; Yamashiro, T | 1 |
| Abbracchio, MP; Jacobson, KA; Jiang, JL; Kim, YC; Sei, Y; Yao, Y | 1 |
| Kobayashi, Y; Watanabe, N; Yamashiro, T | 1 |
| Kobayashi, Y; Sekine, T; Shigenobu, K; Tanaka, H; Terada, M | 1 |
| Kobayashi, Y; Koga, C; Tsuruo, T; Watanabe, N; Yamashiro, T; Yokoyama, KK | 1 |
7 other study(ies) available for ahc 52 and dihydropyridines
| Article | Year |
|---|---|
Therapeutic efficacy of combination of antitumor agent with AHC-52 against multidrug-resistant cells in the intravenously inoculated P388 leukemia model.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Dihydropyridines; Doxorubicin; Drug Resistance; Drug Synergism; Etoposide; Female; Leukemia P388; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Pyrazoles; Vincristine | 1992 |
In vivo circumvention of vincristine resistance in mice with P388 leukemia using a novel compound, AHC-52.
Topics: Animals; Dihydropyridines; Drug Resistance; Drug Synergism; Female; Leukemia P388; Leukemia, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Nifedipine; Pyrazoles; Vincristine | 1989 |
Expression and function of multidrug resistance P-glycoprotein in a cultured natural killer cell-rich population revealed by MRK16 monoclonal antibody and AHC-52.
Topics: Antibodies, Monoclonal; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Cells, Cultured; Cytotoxicity, Immunologic; Dihydropyridines; Drug Resistance; Flow Cytometry; Humans; Immunoglobulin Fab Fragments; Killer Cells, Natural; Molecular Sequence Data; Polymerase Chain Reaction; Pyrazoles; Rhodamine 123; Rhodamines | 1994 |
Adenosine A3 receptor agonists protect HL-60 and U-937 cells from apoptosis induced by A3 antagonists.
Topics: Adenosine; Apoptosis; Dihydropyridines; DNA Fragmentation; Dose-Response Relationship, Drug; HL-60 Cells; Humans; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Pyrazoles; Quinazolines; Triazoles | 1997 |
Reduction of intracellular pH by inhibitors of natural killer cell activity, nicardipine, methyl 2-(N-benzyl-N-methylamino)ethyl-2,6-dimethyl-4-(2-isopropyl-pyrazolo[1, 5-a]pyridine-3-yl)-1,4-dihydro-pyridine-3,5-dicarboxylate (AHC-52), and 4,4'-diisothio
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytotoxicity, Immunologic; Dihydropyridines; Flow Cytometry; Humans; Hydrogen-Ion Concentration; Killer Cells, Natural; Nicardipine; Pyrazoles; Tumor Cells, Cultured | 1997 |
Cardioprotective effect against ischemia-reperfusion injury of AHC-52, a dihydropyridine compound with inhibitory effect on Cl- but not Ca2+ current.
Topics: Animals; Calcium Channels; Cells, Cultured; Chloride Channels; Dihydropyridines; Guinea Pigs; Heart; Heart Ventricles; In Vitro Techniques; Myocardial Reperfusion Injury; Myocardium; Patch-Clamp Techniques; Pyrazoles; Ventricular Function | 1997 |
Requirement of expression of P-glycoprotein on human natural killer leukemia cells for cell-mediated cytotoxicity.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line; Cell Survival; Cytotoxicity, Immunologic; Dihydropyridines; Drug Resistance, Multiple; Humans; Killer Cells, Natural; Nicardipine; Oligonucleotides, Antisense; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrazoles; RNA, Messenger; Thymoma; Thymus Neoplasms; Transcription, Genetic; Tumor Cells, Cultured | 1998 |